Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Treatment of anemia with darbepoetin alfa in systolic heart failure.

Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators.

N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.

PMID:
23473338
[PubMed - indexed for MEDLINE]
Free Article
2.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators.

Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.

PMID:
23329651
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

PMID:
23126252
[PubMed - indexed for MEDLINE]
Free Article
4.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

PMID:
22077192
[PubMed - indexed for MEDLINE]
Free Article
5.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
[PubMed - indexed for MEDLINE]
6.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
[PubMed - indexed for MEDLINE]
7.

[Prevention of perioperative cardiac complications in non-cardiac surgery: an evidence-based guideline].

Damen J, Hagemeijer JW, van den Broek L, Poldermans D; CBO-werkgroep Preventie Perioperatieve Cardiale Complicaties bij Niet-cardiale Chirurgie.

Ned Tijdschr Geneeskd. 2008 Nov 29;152(48):2612-6. Dutch.

PMID:
19102436
[PubMed - indexed for MEDLINE]
8.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
[PubMed - indexed for MEDLINE]
9.

The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population.

Beautiful Study Group, Ferrari R, Ford I, Fox K, Steg PG, Tendera M.

Cardiology. 2008;110(4):271-82.

PMID:
18595216
[PubMed - indexed for MEDLINE]
10.

Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.

Somsen GA, van der Wall EE, van Vlies B, Borm JJ, van Royen EA.

Int J Card Imaging. 1996 Dec;12(4):305-10.

PMID:
8993993
[PubMed - indexed for MEDLINE]
11.

Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Somsen GA, van Vlies B, de Milliano PA, Borm JJ, van Royen EA, Endert E, Lie KI.

Heart. 1996 Sep;76(3):218-22.

PMID:
8868979
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.

Somsen GA, Borm JJ, de Milliano PA, van Vlies B, Dubois EA, van Royen EA.

Eur J Nucl Med. 1995 Oct;22(10):1149-54.

PMID:
8542899
[PubMed - indexed for MEDLINE]
13.

Exclusion of acute myocardial infarction. The value of measuring creatine kinase slope.

Bakker AJ, Koelemay MJ, van Vlies B, Gorgels JP, Smits R, Tijssen JG, Haagen FD.

Eur J Clin Chem Clin Biochem. 1995 Jun;33(6):351-63.

PMID:
7578616
[PubMed - indexed for MEDLINE]
14.

Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.

Valdés Olmos RA, ten Bokkel Huinink WW, ten Hoeve RF, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA.

Eur J Cancer. 1995;31A(1):26-31.

PMID:
7695974
[PubMed - indexed for MEDLINE]
15.

Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction.

Valdés Olmos RA, ten Bokkel Huinink WW, ten Hoeve RF, van Tinteren H, Bruning PF, van Vlies B, Hoefnagel CA.

Ann Oncol. 1994 Sep;5(7):617-22.

PMID:
7993837
[PubMed - indexed for MEDLINE]
16.

Contribution of creatine kinase MB mass concentration at admission to early diagnosis of acute myocardial infarction.

Bakker AJ, Gorgels JP, van Vlies B, Koelemay MJ, Smits R, Tijssen JG, Haagen FD.

Br Heart J. 1994 Aug;72(2):112-8.

PMID:
7917680
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction.

Bakker AJ, Koelemay MJ, Gorgels JP, van Vlies B, Smits R, Tijssen JG, Haagen FD.

Eur Heart J. 1994 Jan;15(1):45-53.

PMID:
8174583
[PubMed - indexed for MEDLINE]
18.

Failure of new biochemical markers to exclude acute myocardial infarction at admission.

Bakker AJ, Koelemay MJ, Gorgels JP, van Vlies B, Smits R, Tijssen JG, Haagen FD.

Lancet. 1993 Nov 13;342(8881):1220-2.

PMID:
7901536
[PubMed - indexed for MEDLINE]
19.

The mass concentrations of serum troponin T and creatine kinase-MB are elevated before creatine kinase and creatine kinase-MB activities in acute myocardial infarction.

Bakker AJ, Gorgels JP, van Vlies B, Haagen FD, Smits R.

Eur J Clin Chem Clin Biochem. 1993 Nov;31(11):715-24.

PMID:
8305615
[PubMed - indexed for MEDLINE]
20.

[Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].

van Vlies B.

Ned Tijdschr Geneeskd. 1992 Sep 12;136(37):1796-8. Review. Dutch. No abstract available.

PMID:
1407135
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk